M O17 (Oxybutynin chloride extended release 15 mg)
Pill imprint M O17 has been identified as Oxybutynin chloride extended release 15 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M O17
- Strength:
- 15 mg
- Color:
- Gray
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6015
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5743 | Physicians Total Care Inc (repackager) |
More about oxybutynin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 203 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
Consumer resources
- Oxybutynin
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More... (4)
Other brands: Ditropan, Ditropan XL, Oxytrol, Gelnique, More... (2)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
